{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:35:47Z","timestamp":1787646947173,"version":"build-2736575974"},"reference-count":67,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jgisurgery.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gastrointestinal Surgery"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.gassur.2024.04.009","type":"journal-article","created":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T07:08:36Z","timestamp":1713856116000},"page":"1194-1205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Efficacy and safety of glucagon-like peptide 2 in patients with short bowel syndrome: a systematic review and network meta-analysis"],"prefix":"10.1016","volume":"28","author":[{"given":"Hamdy Khaled","family":"Sabra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gehad S.","family":"Remeih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibraheem M.","family":"Kereet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Hamad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yassmien Ali","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kainat","family":"Jahangir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa Abdulraheem","family":"Bakr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma Assad","family":"Alagelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadeer","family":"Sherif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2244-4126","authenticated-orcid":false,"given":"Mohamed","family":"Elsaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.gassur.2024.04.009_bib1","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/jpen.2223","article-title":"Apraglutide, a novel glucagon-like peptide-2 analog, improves fluid absorption in patients with short bowel syndrome intestinal failure: findings from a placebo-controlled, randomized phase 2 trial","volume":"46","author":"Eliasson","year":"2022","journal-title":"J Parent Enter Nutr"},{"issue":"3","key":"10.1016\/j.gassur.2024.04.009_bib2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11894-012-0262-8","article-title":"Medical update and potential advances in the treatment of pediatric intestinal failure","volume":"14","author":"Youssef","year":"2012","journal-title":"Curr Gastroenterol Rep"},{"issue":"2","key":"10.1016\/j.gassur.2024.04.009_bib3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.clnu.2014.08.017","article-title":"ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults","volume":"34","author":"Pironi","year":"2015","journal-title":"Clin Nutr"},{"issue":"4","key":"10.1016\/j.gassur.2024.04.009_bib4","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1177\/0148607113512678","article-title":"Short bowel syndrome: highlights of patient management, quality of life, and survival","volume":"38","author":"Kelly","year":"2014","journal-title":"J Parent Enter Nutr"},{"issue":"5","key":"10.1016\/j.gassur.2024.04.009_bib5","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0261-5614(03)00042-6","article-title":"Quality of life and concerns in patients with short bowel syndrome","volume":"22","author":"Carlsson","year":"2003","journal-title":"Clin Nutr"},{"issue":"1","key":"10.1016\/j.gassur.2024.04.009_bib6","article-title":"Clinical, social, and economic impacts of home parenteral nutrition dependence in short bowel syndrome","volume":"38","author":"Winkler","year":"2014","journal-title":"J Parent Enter Nutr"},{"issue":"4","key":"10.1016\/j.gassur.2024.04.009_bib7","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.clnu.2009.04.001","article-title":"ESPEN Guidelines on parenteral Nutrition: Home Parenteral Nutrition (HPN) in adult patients","volume":"28","author":"Staun","year":"2009","journal-title":"Clin Nutr"},{"issue":"7","key":"10.1016\/j.gassur.2024.04.009_bib8","doi-asserted-by":"crossref","first-page":"525","DOI":"10.7326\/0003-4819-132-7-200004040-00003","article-title":"Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure","volume":"132","author":"Cavicchi","year":"2000","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.gassur.2024.04.009_bib9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.clnu.2011.09.009","article-title":"A prospective study of catheter-related complications in HPN patients","volume":"31","author":"Gillanders","year":"2012","journal-title":"Clin Nutr"},{"issue":"6","key":"10.1016\/j.gassur.2024.04.009_bib10","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/gut.44.6.844","article-title":"Quality of life in patients receiving home parenteral nutrition","volume":"44","author":"Jeppesen","year":"1999","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.gassur.2024.04.009_bib11","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.clnu.2006.05.003","article-title":"A review of the quality of life of adult patients treated with long-term parenteral nutrition","volume":"25","author":"Baxter","year":"2006","journal-title":"Clin Nutr"},{"issue":"2","key":"10.1016\/j.gassur.2024.04.009_bib12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/0148607112469818","article-title":"Nutrition and fluid optimization for patients with short bowel syndrome","volume":"37","author":"Matarese","year":"2013","journal-title":"J Parent Enter Nutr"},{"issue":"1","key":"10.1016\/j.gassur.2024.04.009_bib13","first-page":"38S","article-title":"Pharmacologic management of diarrhea in patients with short bowel syndrome","volume":"38","author":"Kumpf","year":"2014","journal-title":"J Parenter Enter Nutr"},{"issue":"6","key":"10.1016\/j.gassur.2024.04.009_bib14","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1053\/j.gastro.2012.09.007","article-title":"Teduglutide reduces need for parenteral support among patients ith short bowel syndrome with intestinal failure","volume":"143","author":"Jeppesen","year":"2012","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.gassur.2024.04.009_bib15","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/01.sla.0000186479.53295.14","article-title":"Growth hormone, glutamine, and an optimal diet reduces parenteral nutrition in patients ith short bowel syndrome: a prospective, randomized, placebo-controlled, double-blind clinical trial","volume":"242","author":"Byrne","year":"2005","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.gassur.2024.04.009_bib16","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1136\/gut.45.4.559","article-title":"Impaired meal stimulated glucagon-like peptide 2 response in ileal resected short bowel patients with intestinal failure","volume":"45","author":"Jeppesen","year":"1999","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.gassur.2024.04.009_bib17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/jpen.1531","article-title":"Determinants of quality of life in patients with intestinal failure receiving long-term parenteral nutrition using the SF-36 questionnaire: a German Single-Center prospective observational study","volume":"44","author":"Bl\u00fcthner","year":"2020","journal-title":"J Parent Enter Nutr"},{"issue":"5","key":"10.1016\/j.gassur.2024.04.009_bib18","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1097\/SLA.0000000000002602","article-title":"Predicting intestinal adaptation in pediatric intestinal failure: a Retrospective Cohort Study","volume":"269","author":"Belza","year":"2019","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.gassur.2024.04.009_bib19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/jpen.1588","article-title":"Impact of teduglutide on quality of life among patients with short bowel syndrome and intestinal failure","volume":"44","author":"Chen","year":"2020","journal-title":"J Parent Enter Nutr"},{"issue":"1","key":"10.1016\/j.gassur.2024.04.009_bib20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jpeds.2015.03.040","article-title":"Predictors of enteral autonomy in children with intestinal failure: a multicenter cohort study","volume":"167","author":"Khan","year":"2015","journal-title":"J Pediatr"},{"key":"10.1016\/j.gassur.2024.04.009_bib21","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jpeds.2016.10.027","article-title":"Outcomes from a 12-week, open-label, multicenter clinical trial of teduglutide in pediatric short bowel syndrome","volume":"181","author":"Carter","year":"2017","journal-title":"J Pediatr"},{"issue":"1-3","key":"10.1016\/j.gassur.2024.04.009_bib22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.regpep.2009.11.001","article-title":"The effect of glucagon-like peptide-2 on arterial blood flow and cardiac parameters","volume":"159","author":"Bremholm","year":"2010","journal-title":"Regul Pept"},{"issue":"3","key":"10.1016\/j.gassur.2024.04.009_bib23","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1080\/00365520802538195","article-title":"Glucagon-like peptide-2 increases mesenteric blood flow in humans","volume":"44","author":"Bremholm","year":"2009","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"10.1016\/j.gassur.2024.04.009_bib24","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/gut.50.3.428","article-title":"Gut adaptation and the glucagon-like peptides","volume":"50","author":"Drucker","year":"2002","journal-title":"Gut"},{"issue":"15","key":"10.1016\/j.gassur.2024.04.009_bib25","doi-asserted-by":"crossref","first-page":"7911","DOI":"10.1073\/pnas.93.15.7911","article-title":"Induction of intestinal epithelial proliferation by glucagon-like peptide 2","volume":"93","author":"Drucker","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"10.1016\/j.gassur.2024.04.009_bib26","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1139\/y03-107","article-title":"Direct and indirect mechanisms regulating secretion of glucagon-like peptide-1 and glucagon-like peptide-2","volume":"81","author":"Brubaker","year":"2003","journal-title":"Can J Physiol Pharmacol"},{"issue":"4","key":"10.1016\/j.gassur.2024.04.009_bib27","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1210\/endo-119-4-1467","article-title":"Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas","volume":"119","author":"\u00d8rskov","year":"1986","journal-title":"Endocrinology"},{"issue":"26","key":"10.1016\/j.gassur.2024.04.009_bib28","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.3748\/wjg.v12.i26.4117","article-title":"Gut hormones, and short bowel syndrome: the enigmatic role of glucagon-like peptide-2 in the regulation of intestinal adaptation","volume":"12","author":"Martin","year":"2006","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.gassur.2024.04.009_bib29","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/MPG.0000000000000335","article-title":"Serum citrulline as a biomarker of gastrointestinal function during hematopoietic cell transplantation in children","volume":"58","author":"Gosselin","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"10.1016\/j.gassur.2024.04.009_bib30","first-page":"181","article-title":"Citrulline as a marker of intestinal function and absorption in clinical settings: a systematic review and meta-analysis. U Eur","volume":"6","author":"Fragkos","year":"2018","journal-title":"Gastroenterol J"},{"issue":"5","key":"10.1016\/j.gassur.2024.04.009_bib31","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jpedsurg.2009.01.034","article-title":"Relationship between serum citrulline levels and progression to parenteral nutrition independence in children with short bowel syndrome","volume":"44","author":"Fitzgibbons","year":"2009","journal-title":"J Pediatr Surg"},{"issue":"8","key":"10.1016\/j.gassur.2024.04.009_bib32","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/jpen.1767","article-title":"Effect of glepaglutide, a long-acting glucagon-like Peptide-2 analog, on gastrointestinal transit time and motility in patients with short bowel syndrome: findings from a randomized trial","volume":"44","author":"Hvistendahl","year":"2020","journal-title":"J Parent Enter Nutr"},{"issue":"1","key":"10.1016\/j.gassur.2024.04.009_bib33","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1136\/gut.47.1.112","article-title":"Glucagon-like peptide-2 enhances intestinal epithelial barrier function of both transcellular and paracellular pathways in the mouse","volume":"47","author":"Benjamin","year":"2000","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.gassur.2024.04.009_bib34","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1080\/00365529850171486","article-title":"Glucagon-like Peptide-2 inhibits centrally induced antral motility in pigs","volume":"33","author":"W\u00f8jdemann","year":"1998","journal-title":"Scand J Gastroenterol"},{"issue":"8","key":"10.1016\/j.gassur.2024.04.009_bib35","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1136\/gut.2008.165886","article-title":"Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability","volume":"58","author":"Cani","year":"2009","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.gassur.2024.04.009_bib36","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1136\/gut.2004.061440","article-title":"Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients","volume":"54","author":"Jeppesen","year":"2005","journal-title":"Gut"},{"issue":"1-3","key":"10.1016\/j.gassur.2024.04.009_bib37","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.regpep.2011.03.003","article-title":"The effect of Glucagon-Like Peptide-2 on mesenteric blood flow and cardiac parameters in end-jejunostomy short bowel patients","volume":"168","author":"Bremholm","year":"2011","journal-title":"Regul Pept"},{"issue":"7","key":"10.1016\/j.gassur.2024.04.009_bib38","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1210\/jcem.84.7.5840","article-title":"Inhibition of sham feeding-stimulated human gastric acid secretion by glucagon-like Peptide-2","volume":"84","author":"W\u00f8jdemann","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.gassur.2024.04.009_bib39","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.gassur.2024.04.009_bib40","first-page":"ED000142","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions","volume":"10","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.gassur.2024.04.009_bib41","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"issue":"oct18 2","key":"10.1016\/j.gassur.2024.04.009_bib42","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.gassur.2024.04.009_bib43","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.gassur.2024.04.009_bib44","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"Robins-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.gassur.2024.04.009_bib45","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1177\/0148607115597644","article-title":"Acute effects of a glucagon-like peptide 2 analogue, teduglutide, on gastrointestinal motor function and permeability in adult patients with short bowel syndrome on home parenteral nutrition","volume":"40","author":"Iturrino","year":"2016","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"6","key":"10.1016\/j.gassur.2024.04.009_bib46","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.clnu.2018.07.006","article-title":"Clinical approach to the management of Intestinal Failure Associated Liver Disease (IFALD) in adults: a position paper from the Home Artificial Nutrition and Chronic Intestinal Failure Special Interest Group of ESPEN","volume":"37","author":"Lal","year":"2018","journal-title":"Clin Nutr"},{"issue":"4","key":"10.1016\/j.gassur.2024.04.009_bib47","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1053\/j.gastro.2017.11.023","article-title":"Factors associated with response to teduglutide in patients with short-bowel syndrome and intestinal failure","volume":"154","author":"Jeppesen","year":"2018","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.gassur.2024.04.009_bib48","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1080\/00365520802200028","article-title":"Effects of treatment with glucagon-like peptide-2 on bone resorption in colectomized patients with distal ileostomy or jejunostomy and short-bowel syndrome","volume":"43","author":"Gottschalck","year":"2008","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.gassur.2024.04.009_bib49","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.regpep.2013.03.023","article-title":"A dose-equivalent comparison of the effects of continuous subcutaneous glucagon-like peptide 2 (GLP-2) infusions versus meal related GLP-2 injections in the treatment of short bowel syndrome (SBS) patients","volume":"184","author":"Naimi","year":"2013","journal-title":"Regul Pept"},{"issue":"7","key":"10.1016\/j.gassur.2024.04.009_bib50","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1136\/gut.2010.218271","article-title":"Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and\/or intravenous fluid requirements in patients with short bowel syndrome","volume":"60","author":"Jeppesen","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.gassur.2024.04.009_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2015.69","article-title":"Long-term teduglutide for the treatment of patients with intestinal failure associated with short bowel syndrome","volume":"7","author":"Schwartz","year":"2016","journal-title":"Clin Transl Gastroenterol"},{"issue":"7","key":"10.1016\/j.gassur.2024.04.009_bib52","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.cgh.2012.12.029","article-title":"Safety and efficacy of teduglutide after 52 weeks of treatment in patients with short bowel intestinal failure","volume":"11","author":"O\u2019Keefe","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.gassur.2024.04.009_bib53","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/MCG.0b013e3182828f57","article-title":"Teduglutide enhances structural adaptation of the small intestinal mucosa in paiths and short bowel syndrome","volume":"47","author":"Tappenden","year":"2013","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.gassur.2024.04.009_bib54","first-page":"1","article-title":"Short bowel patients treated for two years with glucagon-like Peptide 2: effects on intestinal morphology and absorption, renal function, bone and body composition, and muscle function","volume":"2009","author":"Jeppesen","year":"2009","journal-title":"Gastroenterol Res Pract"},{"issue":"4","key":"10.1016\/j.gassur.2024.04.009_bib55","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/jpen.1690","article-title":"Safety and efficacy of teduglutide in pediatric patients with intestinal failure due to short bowel syndrome: a 24-week, phase III study","volume":"44","author":"Kocoshis","year":"2020","journal-title":"J Parent Enter Nutr"},{"issue":"4","key":"10.1016\/j.gassur.2024.04.009_bib56","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1080\/003655202317316006","article-title":"Short-term administration of glucagon-like peptide-2. Effects on bone mineral density and markers of bone turnover in short-bowel patients with no colon","volume":"37","author":"Haderslev","year":"2002","journal-title":"Scand J Gastroenterol"},{"issue":"5","key":"10.1016\/j.gassur.2024.04.009_bib57","first-page":"844","article-title":"Safety and dosing study of glucagon-like peptide 2 in children with intestinal failure","volume":"41","author":"Sigalet","year":"2017"},{"issue":"1","key":"10.1016\/j.gassur.2024.04.009_bib58","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/jpen.2389","article-title":"Effects of glepaglutide, a long-acting glucagon-like peptide-2 analog, on intestinal morphology and perfusion in patients with short bowel syndrome: findings from a randomized phase 2 trial","volume":"47","author":"Naimi","year":"2023","journal-title":"J Parent Enter Nutr"},{"key":"10.1016\/j.gassur.2024.04.009_bib59","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ebiom.2019.07.016","article-title":"Effects of glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, on markers of liver status in patients with short bowel syndrome: findings from a andomized phase 2 trial","volume":"46","author":"Naimi","year":"2019","journal-title":"Ebiomedicine"},{"issue":"5","key":"10.1016\/j.gassur.2024.04.009_bib60","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S2468-1253(19)30077-9","article-title":"Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a andomized phase 2 trial","volume":"4","author":"Naimi","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.gassur.2024.04.009_bib61","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/jpen.2362","article-title":"Apraglutide, a novel once-weekly glucagon-like peptide-2 analog, improves intestinal fluid and energy absorption in patients with short bowel syndrome: an open-label phase 1 and 2 metabolic balance trial","volume":"46","author":"Eliasson","year":"2022","journal-title":"J Parent Enter Nutr"},{"issue":"4","key":"10.1016\/j.gassur.2024.04.009_bib62","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1053\/gast.2001.22555","article-title":"Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon","volume":"120","author":"Jeppesen","year":"2001","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.gassur.2024.04.009_bib63","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cld.2018.12.009","article-title":"Intestinal failure-associated liver disease","volume":"23","author":"Pironi","year":"2019","journal-title":"Clin Liver Dis"},{"issue":"4","key":"10.1016\/j.gassur.2024.04.009_bib64","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/jpen.2224","article-title":"Bile acid\u2013farnesoid X receptor\u2013fibroblast growth factor 19 axis in patients with short bowel syndromthethe randomized, glepaglutide phase 2 trial","volume":"46","author":"Hvistendahl","year":"2022","journal-title":"J Parent Enter Nutr"},{"issue":"6","key":"10.1016\/j.gassur.2024.04.009_bib65","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1053\/gast.2000.20227","article-title":"Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans","volume":"119","author":"Crenn","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gassur.2024.04.009_bib66","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.regpep.2013.03.025","article-title":"Acute effects of continuous infusions of glucagon-like peptide (GLP)-1, GLP-2 and the combination (GLP-1+GLP-2) on intestinal absorption in short bowel syndrome (SBS) patients. A placebo-controlled study","volume":"184","author":"Madsen","year":"2013","journal-title":"Regul Pept"},{"issue":"2","key":"10.1016\/j.gassur.2024.04.009_bib67","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2005.10.066","article-title":"Intestinal failure\u2013associated liver disease: what do we know today?","volume":"130","author":"Kelly","year":"2006","journal-title":"Gastroenterology"}],"container-title":["Journal of Gastrointestinal Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X24004128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X24004128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T13:12:33Z","timestamp":1719925953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091255X24004128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":67,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1091255X24004128"],"URL":"https:\/\/doi.org\/10.1016\/j.gassur.2024.04.009","relation":{},"ISSN":["1091-255X"],"issn-type":[{"value":"1091-255X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of glucagon-like peptide 2 in patients with short bowel syndrome: a systematic review and network meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Gastrointestinal Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gassur.2024.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Society for Surgery of the Alimentary Tract. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}